Markets & customers

Markets-and-CustomersSouth Asia shares a matching oncologic and immunologic profile, albeit with some regional differences. Sayre focuses on the SAARC markets of Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka, where given the high disease burden, Sayre will contribute to improving the quality of care for cancers and autoimmune conditions, by sustained engagement with physicians and providing affordable medicines to patients.

At Sayre Therapeutics, we focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists and rheumatologists.